[go: up one dir, main page]

ES2154311T3 - Quinoxalinas, procedimiento para su preparacion y su utilizacion. - Google Patents

Quinoxalinas, procedimiento para su preparacion y su utilizacion.

Info

Publication number
ES2154311T3
ES2154311T3 ES95116094T ES95116094T ES2154311T3 ES 2154311 T3 ES2154311 T3 ES 2154311T3 ES 95116094 T ES95116094 T ES 95116094T ES 95116094 T ES95116094 T ES 95116094T ES 2154311 T3 ES2154311 T3 ES 2154311T3
Authority
ES
Spain
Prior art keywords
quinoxalinas
procedure
preparation
sup
substitutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95116094T
Other languages
English (en)
Inventor
Manfred Dr Rosner
Uta-Maria Billhardt-Troughton
Reinhard Dr Kirsch
Jorg-Peter Dr Kleim
Christoph Dr Meichsner
Gunther Dr Riess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Application granted granted Critical
Publication of ES2154311T3 publication Critical patent/ES2154311T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

COMPUESTOS DE LA FORMULA I O IA EN DONDE N Y LOS SUSTITUYENTES R{SUP, 1} HASTA R{SUP, 3} ASI COMO X TIENEN LOS SIGNIFICADOS CONOCIDOS, MOSTRANDO UNA ACTIVIDAD ANTIVIRAL.
ES95116094T 1994-10-19 1995-10-12 Quinoxalinas, procedimiento para su preparacion y su utilizacion. Expired - Lifetime ES2154311T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4437406A DE4437406A1 (de) 1994-10-19 1994-10-19 Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ES2154311T3 true ES2154311T3 (es) 2001-04-01

Family

ID=6531202

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95116094T Expired - Lifetime ES2154311T3 (es) 1994-10-19 1995-10-12 Quinoxalinas, procedimiento para su preparacion y su utilizacion.

Country Status (27)

Country Link
US (1) US5723461A (es)
EP (1) EP0708093B1 (es)
JP (1) JPH08225544A (es)
KR (1) KR960014108A (es)
CN (1) CN1094930C (es)
AT (1) ATE198747T1 (es)
AU (1) AU708293B2 (es)
BR (1) BR9504456A (es)
CA (1) CA2160859A1 (es)
CZ (1) CZ271295A3 (es)
DE (2) DE4437406A1 (es)
DK (1) DK0708093T3 (es)
ES (1) ES2154311T3 (es)
FI (1) FI954946L (es)
GR (1) GR3035673T3 (es)
HR (1) HRP950524B1 (es)
HU (1) HUT73485A (es)
IL (1) IL115641A0 (es)
MY (1) MY132057A (es)
NO (1) NO306615B1 (es)
NZ (1) NZ280258A (es)
PL (1) PL184860B1 (es)
PT (1) PT708093E (es)
SI (1) SI9500329A (es)
SK (1) SK128495A3 (es)
TW (1) TW328954B (es)
ZA (1) ZA958783B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369057B1 (en) * 1991-04-15 2002-04-09 Aventis Pharma Deutschland Gmbh Quinoxalines, processes for their preparation and their use
US6015800A (en) * 1997-09-03 2000-01-18 Warner-Lambert Company Substituted quinoxaline-2-ones as glutamate receptor antagonists
WO1999025327A2 (en) * 1997-11-14 1999-05-27 Warner-Lambert Company Small molecule intervention in hiv-1 replication
GB9901795D0 (en) * 1999-01-28 1999-03-17 Glaxo Group Ltd Chemical compounds
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
WO2002087500A2 (en) * 2001-04-27 2002-11-07 Newbiotics, Inc. Viral enzyme activated prototoxophores and use of same to treat viral infections
WO2005018531A2 (en) * 2003-08-26 2005-03-03 'chemical Diversity Research Institute', Ltd. Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
US7351709B2 (en) * 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
SI3459942T1 (sl) 2012-04-24 2021-05-31 Vertex Pharmaceuticals Incorporated Inhibitorji DNA-PK
SG11201507203RA (en) 2013-03-12 2015-10-29 Vertex Pharma Dna-pk inhibitors
JP6408569B2 (ja) 2013-10-17 2018-10-17 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ Ｄｎａ−ｐｋ阻害剤としての（ｓ）−ｎ−メチル−８−（１−（（２’−メチル−［４，５’−ビピリミジン］−６−イル）アミノ）プロパン−２−イル）キノリン−４−カルボキサミドおよびその重水素化誘導体の共結晶
US11110108B2 (en) 2016-09-27 2021-09-07 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT509398E (pt) * 1991-04-15 2002-02-28 Aventis Pharma Gmbh Quinoxalinas processo para a sua preparacao e sua utilizacao
DE4342024A1 (de) * 1993-12-09 1995-06-14 Hoechst Ag Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid

Also Published As

Publication number Publication date
HK1011988A1 (en) 1999-07-23
NO306615B1 (no) 1999-11-29
DK0708093T3 (da) 2001-04-30
AU708293B2 (en) 1999-07-29
ZA958783B (en) 1996-05-09
MY132057A (en) 2007-09-28
FI954946A0 (fi) 1995-10-17
HU9503005D0 (en) 1995-12-28
GR3035673T3 (en) 2001-06-29
IL115641A0 (en) 1996-01-19
SI9500329A (en) 1996-04-30
EP0708093A1 (de) 1996-04-24
NO954139D0 (no) 1995-10-18
CZ271295A3 (en) 1996-08-14
HUT73485A (en) 1996-08-28
US5723461A (en) 1998-03-03
TW328954B (en) 1998-04-01
HRP950524B1 (en) 2002-06-30
AU3431695A (en) 1996-05-02
KR960014108A (ko) 1996-05-22
NO954139L (no) 1996-04-22
DE59508969D1 (de) 2001-02-22
ATE198747T1 (de) 2001-02-15
HRP950524A2 (en) 1997-10-31
DE4437406A1 (de) 1996-04-25
JPH08225544A (ja) 1996-09-03
CN1094930C (zh) 2002-11-27
SK128495A3 (en) 1996-06-05
EP0708093B1 (de) 2001-01-17
PL311016A1 (en) 1996-04-29
CA2160859A1 (en) 1996-04-20
CN1135483A (zh) 1996-11-13
FI954946A7 (fi) 1996-04-20
FI954946L (fi) 1996-04-20
PL184860B1 (pl) 2003-01-31
BR9504456A (pt) 1997-05-20
NZ280258A (en) 1997-09-22
PT708093E (pt) 2001-06-29

Similar Documents

Publication Publication Date Title
ES2162942T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
ES2150989T3 (es) Nuevos derivados de quinoxalinadiona, su preparacion y empleo en medicamentos.
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
DE69912606D1 (de) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivate
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
ES2080739T3 (es) Nitro-compuestos insecticidamente activos.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
MX9203406A (es) Azolilmetiloxiranos y su uso como agentes protectores de cosechas.
WO1999038877A3 (en) 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
AP2000001881A0 (en) 2-(Purine-9-YL)-tetrahydrofuran-3,4 4-diol derivatives.
EA200001224A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
ES2056071T3 (es) Triazolinonas substituidas.
ES2040208T3 (es) Pirazolinas insecticidas.
MX9307974A (es) Nuevos derivados de acido hidroxiiminoalquilindolcarboxilico, su obtencion y uso.
AR241082A1 (es) Nuevos derivados de pirazol utiles como agentes herbicidas, las composiciones herbicidas que los contienen y los procedimientos para producir estos derivados de pirazol".
ES2154311T3 (es) Quinoxalinas, procedimiento para su preparacion y su utilizacion.
ES2060415T3 (es) 1,3-bis(3-(mono- o poli-hidroxi)acilamino-5-(mono- o polihidroxialquil)aminocarbonil-2,4,6-triyodo-benzoilamino)hidroxi- o hidroxialquil-propanos, procedimiento para su preparacion y medios de contraste para rayos x que los contienen.
ES2101858T3 (es) Derivados de geneserina como inhibidores de colinesterasa.
MX9606300A (es) Arilalquiltioalquiltiopiridinas substituidas para combatir bacterias helicobactas.
AR217578A1 (es) Procedimiento para la preparacion de 6,7-dialcoxi-1-piperidinoftalazinas,utiles como agentes terapeuticos
ES2179857T3 (es) Derivados de quinoleina sustituidos, procedimiento para su preparacion y su utilizacion.
IT1092954B (it) Fenilcarbammoil-pirazoline,procedimento per la loro preparazione e il loro impiego come insetticidi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 708093

Country of ref document: ES